Emergent BioSolutions reported $-0.77 in EPS Earnings Per Share for its fiscal quarter ending in December of 2023.





Eps Change Date
Acadia Pharmaceuticals USD 0.31 0.13 Sep/2026
Akebia Therapeutics USD -0.04 0.04 Dec/2025
ALKERMES USD 0.09 0.09 Sep/2026
Alnylam Pharmaceuticals USD 16.26 14.42 Sep/2026
Amarin USD 0.14 0.06 Dec/2025
ANI Pharmaceuticals USD 2.7 0.49 Sep/2026
BioMarin Pharmaceutical USD 0.23 0.97 Sep/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Exelixis USD 0.94 0.03 Sep/2026
Glaxosmithkline GBP 0.76 0.14 Sep/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Ionis Pharmaceuticals USD 0.66 1.35 Sep/2026
Ironwood Pharmaceuticals USD 0.31 0.07 Jun/2026
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
Lonza CHF 6.07 1.92 Jun/2025
Merck USD 2.49 2.62 Sep/2026
Moderna USD 0.38 2.35 Sep/2026
Myriad Genetics USD -0.25 0.16 Jun/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Neurocrine Biosciences USD 3.29 0.44 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
PTC Therapeutics USD -0.62 1.54 Sep/2026
Sanofi EUR 3.55 1.46 Sep/2026
Sarepta Therapeutics USD 0.13 0.51 Sep/2026
United Therapeutics USD 5.71 1.56 Sep/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024